Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1226]

ASCO 2023: Adding pembrolizumab to chemotherapy improves survival in people with advanced cervical cancer

ASCO 2023: Adding pembrolizumab to chemotherapy improves survival in people with advanced cervical cancer 

ASCO 2023: Safety & efficacy of the novel BRAF inhibitor FORE8394 in patients with advanced solid & CNS tumours

ASCO 2023: Safety & efficacy of the novel BRAF inhibitor FORE8394 in patients with advanced solid & CNS tumours

NCCN global policy leader to co-chair GHC's non-communicable diseases roundtable

NCCN global policy leader to co-chair GHC's non-communicable diseases roundtable

Septic shock and metastases: finding the culprits

Septic shock and metastases: finding the culprits

Targeting uncontrolled inflammation may hold the key to treating therapy-resistant cancers

Targeting uncontrolled inflammation may hold the key to treating therapy-resistant cancers

Cervical cancer screening doubles when under-screened women are mailed testing kits

Cervical cancer screening doubles when under-screened women are mailed testing kits

Study highlights racial disparities in ovarian cancer risk for women

Study highlights racial disparities in ovarian cancer risk for women

Discovery could improve survival of bladder cancer patients

Discovery could improve survival of bladder cancer patients

HRD detection predicts sensitivity to platinum-based chemotherapy for ovarian cancer patients in China

HRD detection predicts sensitivity to platinum-based chemotherapy for ovarian cancer patients in China

Researchers present a new approach to the treatment of ovarian cancer using RNA-based nanodrugs – demonstrating an 80% survival rate in lab models

Researchers present a new approach to the treatment of ovarian cancer using RNA-based nanodrugs – demonstrating an...

More from ecancer